Skip to main content

Table 2 Graft function and dialysis early post-transplantation

From: rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

  rhEPO-b group (n = 19) Placebo group (n =20) RR (CI) p
Primary non-function 0 0  
Delayed graft function n (%) 10 (53%) 11 (55%) RR = 1.0 (0.5-1.6) p = 0.93
Slow graft function n (%) 6 (32%) 5 (25%) RR = 1.1 (0.5-1.9) p = 0.73
Days to first dialysis* 1 (1-3) 1 (1-3)  
Number of dialysis episodes* 3 (1-17) 4 (1-19)  
Days to last dialysis* 7 (1-41) 8 (1-35)  
  1. *median (IQR).
\